Our work elucidates the regulatory mechanism of HO-1 in renal sodium metabolism and demonstrates its therapeutic potential for obesity-related, salt-sensitive hypertension. This evidence concerns the gene HMOX1 and obesity due to melanocortin 4 receptor deficiency.